Adial Pharmaceuticals Successfully Completes Manufacturing of Demonstration Batch Production, Enabling Clinical and Registration Production for AD04 Planned Phase …

Demonstration batch production achieves all prespecified test specifications for dissolution, content uniformity, blend ...

Exclusive: Adial Pharmaceuticals clears manufacturing milestone ahead of pivotal study for alcohol use disorder drug

Adial Pharmaceuticals Inc. ADIL said Wednesday it has completed demonstration batch production for its lead candidate AD04, ...
TMCnet

Lantern Pharma Launches withZeta.ai - the World's First Multi-Agentic A.I. Co-Scientist for Rare Cancer Drug Discovery & Development - Subscriptions Now Open; Debut Events at ...

PM Eastern, Lantern Pharma will host an exclusive live demonstration of withZeta.ai at Nasdaq MarketSite in New York City - one of the world's most recognized venues for presenting innovation to the ...
Business Wire

Lantern Pharma Invites Investors, Analysts & Shareholders to Experience the Future of Drug Discovery via a Live Demo of withZeta.ai — the World's First Multi-Agentic Co ...

DALLAS--(BUSINESS WIRE)--Lantern Pharma Inc. (Nasdaq: LTRN) (“Lantern” or the “Company”), an AI-driven clinical-stage precision oncology company, today announced it will host an investor, analyst and ...
P.M. News

NAFDAC considers Indigenous Pharma Tech as Symmex unveils Huraflow-MES

Nigeria may be on the brink of a major shift in pharmaceutical manufacturing regulation and innovation, following the ...

Adial Pharmaceuticals, Inc: Adial Pharmaceuticals Successfully Completes Manufacturing of Demonstration Batch Production, Enabling Clinical and Registration Production for AD04 ...

Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) ("Adial" or the "Company"), a clinical-stage biopharmaceutical company focused on developing therapies for ...